Quantitative MRI using relaxometry in malignant gliomas detects contrast enhancement in peritumoral oedema

Sci Rep. 2020 Oct 22;10(1):17986. doi: 10.1038/s41598-020-75105-6.

Abstract

Malignant gliomas are primary brain tumours with an infiltrative growth pattern, often with contrast enhancement on magnetic resonance imaging (MRI). However, it is well known that tumour infiltration extends beyond the visible contrast enhancement. The aim of this study was to investigate if there is contrast enhancement not detected visually in the peritumoral oedema of malignant gliomas by using relaxometry with synthetic MRI. 25 patients who had brain tumours with a radiological appearance of malignant glioma were prospectively included. A quantitative MR-sequence measuring longitudinal relaxation (R1), transverse relaxation (R2) and proton density (PD), was added to the standard MRI protocol before surgery. Five patients were excluded, and in 20 patients, synthetic MR images were created from the quantitative scans. Manual regions of interest (ROIs) outlined the visibly contrast-enhancing border of the tumours and the peritumoral area. Contrast enhancement was quantified by subtraction of native images from post GD-images, creating an R1-difference-map. The quantitative R1-difference-maps showed significant contrast enhancement in the peritumoral area (0.047) compared to normal appearing white matter (0.032), p = 0.048. Relaxometry detects contrast enhancement in the peritumoral area of malignant gliomas. This could represent infiltrative tumour growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / metabolism
  • Contrast Media / metabolism*
  • Edema / diagnosis*
  • Edema / metabolism
  • Female
  • Glioma / diagnosis*
  • Glioma / metabolism
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Male
  • Middle Aged
  • Radiographic Image Enhancement / methods*

Substances

  • Contrast Media